ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Pittsburgh, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Human Influenza
Post-Acute COVID-19 Syndrome
Respiratory Distress Syndrome

COVID-19 trials near Pittsburgh, PA, USA:

AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...

Active, not recruiting
COVID-19
Biological: Placebo
Biological: Remdesivir

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Pittsburgh, Pennsylvania, United States and 123 other locations

for infectious pneumonia acquired in the community (CAP), including COVID-19.Secondary objectives:- To determine the effect of repa...

Enrolling
Severe COVID-19
Infectious Pneumonia
Other: Placebo
Drug: Reparixin

Phase 3

Dompé
Dompé

Pittsburgh, Pennsylvania, United States and 106 other locations

Study of EDP-235 in Non-hospitalized Adults with Mild or Moderate COVID-19....

Enrolling
COVID-19
Drug: Placebo
Drug: EDP-235

Phase 2

Enanta Pharmaceuticals
Enanta Pharmaceuticals

Smithfield, Pennsylvania, United States and 20 other locations

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Pittsburgh, Pennsylvania, United States and 59 other locations

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Sub-study)
Biological: Placebo (Parent study Sentinel Safety Cohort)

Phase 2, Phase 3

AstraZeneca
AstraZeneca

Pittsburgh, Pennsylvania, United States and 214 other locations

study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 2, Phase 3

Pfizer
Pfizer

Pittsburgh, Pennsylvania, United States and 105 other locations

the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...

Enrolling
Myocarditis
Diagnostic Test: Cardiac Imaging

Phase 4

Pfizer
Pfizer

Pittsburgh, Pennsylvania, United States and 35 other locations

The study will evaluate the safety, tolerability, reactogenicity, and effectiveness of mRNA-1273.214 severe acute respiratory syndrome coronavirus 2...

Enrolling
SARS-CoV-2
Other: Placebo
Biological: mRNA-1273.214

Phase 2

Moderna
Moderna

Pittsburgh, Pennsylvania, United States and 51 other locations

This study will enroll individuals who have:* Completed primary series of mRNA COVID-19 vaccine, and* An antibody response ≤ 2500 U-...

Active, not recruiting
Liver Transplant Recipients
Kidney Transplant Recipients
Biological: Moderna COVID-19 Vaccine 2023-2024
Biological: Pfizer-BioNTech COVID-19 Vaccine 2023-2024

Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

Pittsburgh, Pennsylvania, United States and 14 other locations

chain reaction \[RT-PCR\] test) and have coronavirus disease 2019 (COVID-19) symptom(s) with S-217622 tablets compared with placebo...

Enrolling
SARS-CoV-2 Infection
Drug: Placebo
Drug: S-217622

Phase 3

Shionogi
Shionogi

Scottdale, Pennsylvania, United States and 97 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems